A critique of a joint health-group position statement on vaping
Source material dated October 2021 · Agencies and guidance
Overview
This page summarises a 2021 article that criticised a joint position statement on vaping issued by a group of Australian health organisations, including a quit-smoking body, a heart charity, a lung charity and a public health association. The source argued the statement gave too little weight to the harm of continued smoking and handled several risks selectively. The organisations' own reasoning is not reproduced here.
The source's main objections
Harm reduction framing. The source argued that any risks of vaping should be weighed against continued smoking, and reported that regular vaping in Australia was largely confined to current and former smokers. It said the statement did not make that comparison.
Effectiveness. The statement had cited a lack of evidence of effectiveness. The source disagreed, citing randomised trials it said showed higher quit rates than nicotine replacement, observational studies, and its figures on how many Australian smokers used vaping in 2019 compared with other quitting aids.
Specific health concerns. The source addressed seizures, arterial stiffness, cardiovascular disease, lung damage, poisoning and battery injuries one by one. In each case it argued that the evidence was weak, mixed or limited to short-term or laboratory effects, and that harms from smoking were larger. It reported that a widely cited study on heart disease had been retracted and that other work suggested improvement when smokers switched.
Gateway and relapse. The source argued that association between youth vaping and smoking does not show cause, and that relapse to smoking is common after quitting by any method.
Context and limits
The article uses strongly critical language about the organisations, which this summary does not adopt. Many of the source's points rest on its reading of contested studies, and the position statement may have been revised since 2021. Nothing here is a statement about health outcomes; readers wanting evidence should consult the cited research and current official guidance.
Based on a 2021 opinion article.
Related summaries
- A journal critique of a national research council statement on e-cigarettes
- Senate estimates questioning on Australia's 2021 vaping regulations
- Criticism of a national research council's 2022 vaping guidance
- A 2017 critique of a medical association submission to a federal e-cigarette inquiry